Maricel Apuli Bridge Bio Pharma, Inc. (BBIO) insider trading activity

BBIO Quotes by TradingView

Maricel Apuli is Chief Accounting Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 137,078 shares of BBIO, which is worth approximately $7.06 Million. The most recent transaction as insider was on Aug 16, 2025, when has been sold 4,781 shares (Common Stock) at a price of $51.32 per share, resulting in proceeds of $245,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
4.05% 3M change
n/a 12M change
Total Value Held $7.06 Million

Maricel Apuli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2025
SELL
Payment of exercise price or tax liability
$245,360 $51.32 p/Share
4,781 Reduced 3.37%
137,078 Common Stock
Aug 07 2025
SELL
Open market or private sale
$45,440 $45.44 p/Share
1,000 Reduced 0.7%
141,859 Common Stock
May 16 2025
SELL
Payment of exercise price or tax liability
$161,755 $33.84 p/Share
4,780 Reduced 3.24%
142,859 Common Stock
May 02 2025
SELL
Open market or private sale
$39,511 $38.51 p/Share
1,026 Reduced 0.69%
147,639 Common Stock
Mar 19 2025
BUY
Grant, award, or other acquisition
-
23,660 Added 13.73%
148,665 Common Stock
MA

Maricel Apuli

Chief Accounting Officer
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BBIO